The cash number is not the real story; the settlement mainly clears an extreme tail outcome that was never likely to be priced in fully, while leaving the strategic overhang intact. What matters is that the company has now conceded product-level constraints in a national case, which creates a template for future plaintiffs and regulators to push beyond dollars into feature design. That typically compresses the multiple more than it hits the current-year P&L.

The revenue risk is second-order but meaningful over a 6-18 month horizon: teenage users are not the largest monetization bucket today, but they are the highest-value future cohort for habit formation, Reels engagement, and advertiser targeting depth. If compliance tools, age verification, and usage caps add friction, the cost is not just lost minutes; it is slower engagement compounding and a weaker path to premium CPMs. That is where competitors with less regulatory drag can quietly gain share in attention and ad budgets.

Contrarianly, the market may be overestimating the near-term earnings hit and underestimating the precedent value of the settlement. If court approval is slow, or if other states copy the same playbook, META faces a rolling legal discount rate on the stock. The thesis breaks if management shows no measurable deterioration in time spent, DAU mix, or ad pricing on the next two prints and if courts make the product restrictions narrower than expected.